Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Fervenza

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Annals of the Rheumatic Diseases|January 26, 2023
Risk factors for serious infections in ANCA-associated vasculitisBalazs Odler, Regina Riedl, Philipp Gauckler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient SubsetsEli M Miloslavsky, Na Lu, Sebastian Unizony, et al.
Annals of the Rheumatic Diseases|December 2, 2015
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA typeSebastian Unizony, Miguel Villarreal, Eli M Miloslavsky, et al.
Journal of the American Society of Nephrology : JASN|March 15, 2023
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKDHiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, et al.
Rheumatology (Oxford, England)|January 18, 2018
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitisDivi Cornec, Brian F Kabat, John R Mills, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Annals of the Rheumatic Diseases|January 26, 2023
Risk factors for serious infections in ANCA-associated vasculitisBalazs Odler, Regina Riedl, Philipp Gauckler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient SubsetsEli M Miloslavsky, Na Lu, Sebastian Unizony, et al.
Annals of the Rheumatic Diseases|December 2, 2015
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA typeSebastian Unizony, Miguel Villarreal, Eli M Miloslavsky, et al.
Journal of the American Society of Nephrology : JASN|March 15, 2023
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKDHiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, et al.
Rheumatology (Oxford, England)|January 18, 2018
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitisDivi Cornec, Brian F Kabat, John R Mills, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Pageof 2